Cargando…
ndufa7 plays a critical role in cardiac hypertrophy
Cardiac hypertrophy is a common pathological change in patients with progressive cardiac function failure, which can be caused by hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM) or arterial hypertension. Despite years of study, there is still limited knowledge about the underlying mo...
Autores principales: | Shi, Xingjuan, Zhang, Yu, Chen, Ru, Gong, Yijie, Zhang, Mingming, Guan, Rui, Rotstein, Ori D., Liu, Xiangdong, Wen, Xiao‐Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701565/ https://www.ncbi.nlm.nih.gov/pubmed/32989924 http://dx.doi.org/10.1111/jcmm.15921 |
Ejemplares similares
-
Ndufa6 regulates adipogenic differentiation via Scd1
por: Zhang, Jingwei, et al.
Publicado: (2021) -
HOPX Plays a Critical Role in Antiretroviral Drugs Induced Epigenetic Modification and Cardiac Hypertrophy
por: Kashyap, Shiridhar, et al.
Publicado: (2021) -
BMAL1 plays a critical role in the protection against cardiac hypertrophy through autophagy in vitro
por: Yu, Lei, et al.
Publicado: (2022) -
NDUFA4L2 promotes trastuzumab resistance in HER2-positive breast
cancer
por: Yuan, Yuan, et al.
Publicado: (2021) -
NDUFA12L mitochondrial complex-I assembly factor: Implications for taupathies
por: Salama, Mohamed, et al.
Publicado: (2015)